Clinical evaluation and ultrasound examination are the first steps in the evaluation of a patient with a swelling of the parotid region. After the detection of a nodular lesion, cytological or histological confirmation is usually performed to achieve the diagnosis, while the choice of cross-sectional imaging (computed tomography scan and magnetic resonance imaging) may significantly vary from one physician to another, on the basis of the degree of confidence that both radiologist and surgeon have with this kind of imaging. This work focuses on some essential "reporting points" in cross-sectional imaging evaluation of parotid nodules, chiefly helpful to the radiologist when the ultrasonography assessment is considered incomplete and requires a further evaluation.
Introduction
S alivary glands may be affected by various pathologies of inflammatory, infective, obstructive, or neoplastic origin.
In particular, the neoplastic potential is expressed by a range of benign and malignant lesions with over 45 identifiable different histotypes, which, though not frequently (<3% of head and neck tumors), has no equal in any other organ or apparatus. [1] Salivary gland tumors are most frequently identified in the parotid gland (80% of cases), while the involvement of submandibular gland, sublingual glands, or minor salivary glands rarely occurs. [1] The study of parotid nodular lesions relies quite often on diagnostic imaging, which is of fundamental importance for planning surgical interventions. Ultrasonography (US), preceded by an accurate clinical evaluation, is the first essential approach in a patient presenting tumefaction of the parotid region, while performing a multidetector computed tomography (CT) or a magnetic resonance (MR) examination is a choice that may vary significantly from one physician to another. region of the external acoustic meatus to the angle of the mandible. [2] The parotid space is posterior to the masticator space, external to the parapharyngeal space, and anterolateral to the carotid space. [2] It is delimited by the parotid fascia, which originates in the superficial layer of the deep cervical fascia, and surrounds the parotid gland, passing through it and forming a series of sects and subdividing the parenchyma into lobuli.
The external carotid artery and retromandibular vein pass through the parotid gland, as well as extracranial ramifications of the facial nerve, which emerges from the stylomastoid foramen.
Although it cannot be considered as a proper anatomical subdivision, a superficial lobe (the palpable portion of the gland) and a deep lobe can be identified, using the pathway of the facial nerve and its intraparotid branches as anatomical reference. In axial CT and MR images, this pathway might be identifiable by joining the stylomandibular foramen and the external margin of the retromandibular vein in a straight line [ Figure 1a ]. [2] Stensen's duct originates in the anterior margin of the parotid gland extending horizontally forward, along the external margin of the masseter muscle, 1-2 cm below the zygomatic arch. Beyond the masseter muscle, the parotid duct passes through the buccinator muscle, ending in the oral cavity at the level of the superior vestibule of the mouth, in the proximity of the second molar. [3] An accessory parotid lobe may be present in 21% of participants, located about 5-6 mm in front of the main gland, along the pathway of the Stensen's duct [ Figure 1b ]. [4, 5] In other cases, an anterior extension of the gland may be seen along the masseter muscle.
The parotid space, finally, also includes a series of periglandular and intraglandular (about 10-20) lymph nodes, located mainly on the surface of the parotid gland: diameter is normally up to 8 mm.
The anatomical subdivision into lobes is helpful, since the surgeon's aim, when removing nodular lesions in the parotid, is always to safeguard the facial nerve, performing a superficial parotidectomy in most cases, if the lesion is external to the nerve, or a total parotidectomy in the case of deep lesions.
Imaging Modalities: Is Ultrasonography Always Conclusive?
On the basis of anatomical and anatomopathological aspects and surgical implications, radiological evaluation of the parotid nodular lesions may appear to be complex.
However, it is not so challenging taking into consideration what the real potential of diagnostic imaging is.
It is important to keep in mind that most of parotid gland tumors are benign (80%-95%): [6, 7] the most common is pleomorphic adenoma (60% of all salivary gland tumors), followed by, in decreasing order of incidence, Warthin's tumor, basal cell adenoma, and oncocytoma. [8] As for malignant tumors (10% to 25%), the most frequents are mucoepidermoid carcinoma, adenoid cystic carcinoma, and squamous carcinoma. [7] After a clinical evaluation of a parotid swelling, even if asymptomatic, a US examination should be carried out, as the first step in the radiological framework.
Typical sonographic characteristics of benignity are well-defined margins, homogeneous echotexture, hypoechogenicity, round or ovoid shape, calcifications, and vascularization (Grade 1-2), while sonographic characteristics suggesting malignancy are irregular shape, spiculated or ill-defined margin, heterogeneous echotexture, vascularization (Grade 3-4), and the presence of large cervical lymphadenopathy. [9] On the basis of the above-mentioned relieves, US has demonstrated a specificity that can range from 40% to 84%, a specificity of 88%-98%, and an accuracy of 57%-96%. [10] Moreover, other US techniques, including elastography, color Doppler, and contrast-enhanced US (CEUS), can be exploited in the evaluation of parotid nodules.
Elastography is a relatively new technique, generally used in thyroid or breast imaging, whose aim is to evaluate the stiffness of the lesions.
Actually, two types of elastography are performed: strain elastography (SE) and share-wave elastography (SWE). SE produces colored stiffness maps of the lesions as the result of the comparison of the sonographic beam before and after a compression performed by the operator. [6] Although for breast and thyroid lesions, the stiffness is directly related to the malignant lesions, the characterization of parotid nodules is more challenging, due to their variable histoarchitecture, and overlapping features between malignant and benign can be seen. [11] On the other hand, SWE exploits the formation of acoustic waves, perpendicular to the sonographic bean, that distribute into the tissues surrounding the lesions. Consequently, the evaluation of the stiffness is less dependent on the operator compression and more easily reproducible. [12] However, neither this technique allowed a certain differentiation between benign and malignant lesions. [6] Color Doppler sonography evaluates macrovascularity of the lesions. Usually, a peripheral vascularization pattern is related to benignity, while an intranodular blood flow can be suspicious for malignancy. [13] Unfortunately, this kind of evaluation strictly depends on the subjective evaluation and the experience of the operator. [14] On the other hand, CEUS, obtained after the intravenous injection of a microbubble contrast agent, allows a real-time visualization of the lesions' perfusion. [14] Usually, different types and subtypes of microvascularization can be distinguished, and the heterogeneous enhancement in lesions with ill-defined margins is generally associated with malignancy. [13] Several authors suggested that a multiparametric appraisal of the parotid lesions, performed with all or some of the supra-mentioned sonographic technique and tools, could significantly improve the specificity in distinguishing benign and malignant lesions, although, up to now, precise differentiation criteria are not well established. [13] [14] [15] However, the final characterization of the parotid lesions can be easily performed through cytological (fine-needle aspiration cytology [FNAC]) or histological (core needle biopsy [CNB]) procedures, to get a certain diagnosis with a high degree of accuracy. [16] [17] [18] However, in some cases, the clinical picture might be still incomplete and some diagnostic questions, which can be significant to choose the most suitable surgical approach, might remain unanswered.
Cross-sectional Imaging Modalities: The Pros and Cons
When evaluating parotid gland lesions, the choice of the imaging modality is based on different considerations.
CT scan is a worldwide spread, rapid, and "low-cost" examination whose images are characterized by an excellent contrast resolution. CT scan leads to an accurate appraisal of parotid lesions, allowing to recognize localization, sizes, margins and density, presence of intranodular calcification, invasion of the surrounding tissues, and infiltration of bone or cartilaginous structures.
Moreover,
encouraging results for what concern evaluation of conspicuity, differential diagnosis (i.e., between neoplastic and inflammatory lesions), and lymph node involvement derives from dual-energy CT, thorough its helpful tool techniques, including iodine overlay, bone removal, and virtual monoenergetic imaging. [19, 20] However, although its use is suggested especially in noncompliant patients, the major limit of CT scan remains the radiation exposure.
On the contrary, MRI is a radiation-free imaging modality that can achieve higher values of sensitivity and specificity for what concern the morphological and volumetric assessment, the lesion components, the extraglandular extension, and the perineural spread. [21] and apparent diffusion coefficient (ADC) calculation. [22] [23] [24] Furthermore, functional imaging modalities failed in providing definite relieves of malignancy.
In fact, the role of DCE examination has been evaluated on both CT scan and MRI sides.
On the basis of the time-intensity curve, four types of enhancement pattern have been described for parotid gland lesion (delayed enhancement, Type A;
Nevertheless, in some cases, the high costs and the prolonged scanning time may discourage its use. [22] The accuracy of MRI can be even more increased with the complement of dynamic contrast-enhanced MRI (DCE-MRI), diffusion-weighted imaging (DWI), rapid enhancement and >30% washout, Type B; rapid enhancement and 30%-10% washout, Type C; and rapid enhancement and low or no washout, Type D). [25] However, although some patterns can be suggestive of malignancy, the collected data for both the techniques are still overlapping and not definite. [26, 27] Even DWI and ADC, in the differentiation of benign and malignant nodules, showed similar features and conflicting results among different studies. [24, 28] In fact, although previous researches had evaluated the accuracy of DWI in distinguishing pleomorphic adenomas and myoepithelial adenomas [28] and beyond the fact that ADC calculation can be useful in detecting early inflammatory or neoplastic changes in the parotid gland, [23] up to now, DWI did not show pathognomonic relieves and a univocal ADC cutoff is not yet established. Therefore, they can be considered helpful tools but not alone sufficient for a definitive characterization. [23, 24, 29, 30] 
Cross-sectional Imaging of Parotid Nodules: Referring Key Points
Beyond the clear limitations of these techniques in the characterization of the parotid lesions, cross-sectional imaging can still be important for the surgical planning.
What?
For what concern the differentiation between benign and malignant nodules, it needs to be kept in mind that usual signs of benignity are sharp margins, round shape, homogeneous density at CT scan, and hyperintensity on T2-weighted MRI images. [22, 31] Instead, hypointensity on T2-weighted MRI images, irregular or poorly defined margins, and infiltration into surrounding tissue (parapharyngeal space, muscles, and bone) can be considered suspicious for malignancy. [25, 29, 32] Where? Due to the comprehensive evaluation of the parotid gland and the surrounding tissues, CT scan and MRI can easily distinguish the intra-or extraglandular site of a parotid lesion [ Figures 2 and 3 ].
In nodules originating in the adjacencies of the mandibular angle, it is important to depict the exact anatomical configuration of the lower pole of the parotid gland and of the submandibular gland, to identify the exact site of origin of the lesion [ Figure 4 ].
In addition, US might not permit a definite evaluation of the real depth of a parotid lesion. In fact, when a tumor has involved the deep lobe, a more drastic surgical approach is needed, requiring a total parotidectomy.
Cross-sectional imaging is also very useful in distinguishing between lesions arising from deep parotid gland and primary parapharyngeal space masses.
Larger lesions of the deep lobe, expanding toward the median line, tend to compress the adipose tissue of the parapharyngeal space, which will, instead, be obliterated in the case of expanding lesions originating from the same space [ Figure 5] .
Moreover, the radiologist should be aware of the possible localization of the nodules into the accessory lobe, an ectopic glandular tissue separated or contiguous, usually anterior to the main gland. In fact, the typical clinical appearance of these kinds of lesions consists in a swelling of the cheek [ Figures 6 and 7 ].
How many?
With regard to the number of lesions, cross-sectional imaging helps to better evaluate glandular areas located in sites more difficult to examine at US, due to their particular anatomical position [ Figures 8 and 9 ]. [4] True or false? It must be pointed out how a swelling in the preauricular region, negative at US of the parotid space, may yet conceal a pathology, but located outside of the parotid gland. The so-called "pseudolesions" may include synovial chondromatosis of the temporomandibular joint, pathologies of the lower jaw, or unilateral hypertrophy of the masseter. [33] In such cases, cross-sectional techniques make it possible to observe anatomical structures bilaterally, allowing a comparative evaluation [ Figure 10 ]. [34] Figure 10: A 37-year-old female patient with swelling of the left preauricular region, negative at ultrasonography scan. Axial T2-weighted magnetic resonance scan easily demonstrates a unilateral hypertrophy of the left masseter muscle (asterisk).
